Transplantation acceptance or rejection is determined by the cumulative effects of innate as well as adaptive responses to the foreign graft, however, the role of innate immunity in transplant rejection had been less studied than adaptive immunity. A focus on innate immunity is timely due to the discovery of Toll-like receptors (TLR's) in mammalian cells, which has revolutionized the field. The focus of this proposal is a member of a new family of genes called the CATERPILLAR family. Members are defined by shared motifs, including the caspase activation and recruitment domain (CARD), transcriptional enhancement domain, purine-binding domain, pyrin, and leucine rich domain. Others have also called this the NALP or NOD family. One of the CATERPILLAR genes, which we call Monarch-1, is only expressed by myeloid and monocytic cells. Its expression in primary monocytes is abrogated upon TLR activation through various agonists. When over-expression in non-monocytic/myeloid cell lines, Monarch-1 represses NF-kB/AP-1 activation. Thus it may be a negative regulator of inflammatory responses. In transplantation, negative regulators may be important for enhancing transplant acceptance. The goal fo this proposal is to further explore the role of Monarch-1 in myeloid/monocytic cells, and in cardiac and kidney transplant rejection.
The Aims are: (1) To produce a large number of myeloid-monocytic cell lines which lack Monarch-1 expression by the RNA interfenence (RNAi) technology. (2) To delineate the role of Monarch-1 in these cell lines in the activation of NF-KB and AP-1, in cytokine synthesis, and in overall gene expression profile. (3) To characterize Monarch-1 expression during kidney and cardiac transplantation. (4) To characterize the role of Monarch-1 in kidney and cardiac transplanttation by producing and using mice that lack the Monarch-1 gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
2P01DK038108-16A1
Application #
6909159
Study Section
Special Emphasis Panel (ZDK1-GRB-D (J1))
Project Start
2005-04-01
Project End
2010-03-31
Budget Start
2005-04-01
Budget End
2006-07-31
Support Year
16
Fiscal Year
2005
Total Cost
$248,378
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Allen, Irving C; Lich, John D; Arthur, Janelle C et al. (2012) Characterization of NLRP12 during the development of allergic airway disease in mice. PLoS One 7:e30612
Allen, Irving C; Jania, Corey M; Wilson, Justin E et al. (2012) Analysis of NLRP3 in the development of allergic airway disease in mice. J Immunol 188:2884-93
DiLillo, David J; Griffiths, Robert; Seshan, Surya V et al. (2011) B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol 186:2643-54
Ting, Jenny P Y; Duncan, Joseph A; Lei, Yu (2010) How the noninflammasome NLRs function in the innate immune system. Science 327:286-90
Arthur, Janelle C; Lich, John D; Ye, Zhengmao et al. (2010) Cutting edge: NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 185:4515-9
Facemire, Carie S; Griffiths, Robert; Audoly, Laurent P et al. (2010) The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background. Hypertension 55:531-8
Jania, Leigh A; Chandrasekharan, Subhashini; Backlund, Michael G et al. (2009) Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat 88:73-81
Crowley, Steven D; Vasievich, Matthew P; Ruiz, Phillip et al. (2009) Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J Clin Invest 119:943-53
Crowley, Steven D; Frey, Campbell W; Gould, Samantha K et al. (2008) Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am J Physiol Renal Physiol 295:F515-24
O'Connor, Brian P; Eun, So-Young; Ye, Zhengmao et al. (2008) Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses. Proc Natl Acad Sci U S A 105:13015-20

Showing the most recent 10 out of 82 publications